Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     General & Plastic Surgery     Ablation Devices     Radiation Ablators    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Global Brachytherapy Market

  • Report Code: HE 1056
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The Global Brachytherapy Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing procedures through minimal invasive surgery was pegged at $215 million in 2013 and expected to be $245 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body.

The report “Brachytherapy Market forecast, 2010-2018 “analyzes the market of devices by segments such as High Dose Rate Brachytherapy, Pulsed Dose Rate Brachytherapy, and Permanent Seed Brachytherapy. The technique has been successfully used against cancers of cervix, prostate, breast and skin cancers.

Older population is growing in the mature markets such as Japan, U.S. and in the Western European countries. Currently, one quarter of the Japanese population is aged 65 and older. Currently, in the U.S., 40 million people are of age 65 and above and is expected that, by 2050 this number will double to 89 million diseases such as cancer, cardiovascular disorders, gynecological, and orthopedic problems increases. As the number of patient population will increase it will lead to increase in the procedural volume of minimally invasive surgeries, ultimately giving rise to increased demand for brachytherapy.

Factors such as high patient pool, growing preferences to minimally invasive surgery, geographical expansion of market players, increased government investment in healthcare facilities especially in rural areas, westernization in life style and dietary habits, increasing healthcare expenditure & improving medical insurance plans, are driving the brachytherapy market.

Emerging markets such as India, China, and Brazil have undergone significant economic development over the past decade. This development has also led to an increase in healthcare availability in these countries. Also, as these countries have relatively modest GDP per capita levels and highly variable healthcare systems, the need for inexpensive ablation devices is emerging as an important factor. It has provided an opportunity for brachytherapy market companies, to have an established and growing market in these countries.

The report also provides an extensive competitive landscaping of companies operating in Brachytherapy market. The main companies operating in Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).

Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.

Customization Options:

With Market data, you can also customize MMM assessments that meet your Company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:

Product Analysis

  • Usage pattern (in-depth trend analysis) of products (Segment wise)
  • Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
  • End-user Adoption rate analysis of the products (Segment wise and Country wise)
  • Comprehensive coverage of Product approvals, Pipeline products and Product recalls

Epidemiology Data

  • Country specific Prevalence of cancer, cardiovascular disorders, gynecological, and orthopedic disorders.
  • Country specific Patient pool of cancer, cardiovascular disorders, gynecological, and orthopedic disorders.
  • Disease progression (Pattern analysis)

Surgeons/Physicians Perception Analysis

 

  • Fast turn-around analysis of Surgeons response to market events and trends
  • Surgeons opinion about products from different companies
  • Surgeons qualitative inputs on epidemiology date

Brand/Product Perception Analysis

  • Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)

Alternative Products: Impact analysis



1    Introduction                        
    1.1    OVERVIEW                           
    1.2    OBJECTIVES OF STUDY                    
    1.3    MARKETS DEFINITION
        1.3.1    Market Covered                
    1.4    STAKEHOLDERS                         
    1.5    RESEARCH METHODOLOGY                    
        1.5.1    MARKET SIZE                 
        1.5.2    MARKET SHARE                
        1.5.3    KEY DATA POINTS FROM SECONDARY SOURCES                 
        1.5.4    KEY DATA POINTS FROM PRIMARY SOURCES                 
    1.6    AUXILLIARY FACTORS                   
    1.7    ASSUMPTIONS                       
    1.8    LIST OF ACRONYMS                                
                            
2    Executive Summary                        
                            
3    Market Overview                        
    3.3.1    DRIVERS                    
        3.3.1.1    Rising number of cancer patients around the world                
        3.3.1.2    Low cost of brachytherapy devices to boost the market                
        3.3.1.3    Improved efficiency and shorter time required for treatment to drive the market               3.3.1.4    Others                
    3.3.2    RESTRAINTS                    
        3.3.2.1    Less acequrate targeted theraphy damages neighbouring healthy cells                
        3.3.2.2    Introduction of advanced radiotherapy                
        3.3.2.3    Others                
                            
    3.3.3    OPPORTUNITIES                    
    3.3.4    SUPPORTING DATA                    
        3.3.4.1    Healthcare Expenditure                
                            
4    Global Brachytherapy Market, By Technology                        
    4.1    LOW DOSE RATE                    
    4.2    HIGH DOSE RATE                    
                            
5    Global Brachytherapy Market, By Product                        
    5.1    SEEDS                    
    5.2    APPLICATORS                    
                            
6    Global Brachytherapy Market, By Applications                        
    6.1    BREAST CANCER                     
    6.2    CERVICAL CANCER                    
    6.3    GYNAECOLOGICAL CANCER                    
    6.4    LUNG CANCER                    
    6.5    PROSTATE CANCER                    
    6.6    PENILE CANCER                    
    6.7    ESOPHAGUS CARCINOMA                    
    6.8    HEAD AND NECK CANCER                    
                            
7    Geographic Analysis                        
    7.1    NORTH AMERICA                    
    7.2    EUROPE                    
    7.3    ASIA                    
    7.4    ROW (REST OF THE WORLD)                     
                            
8    Competitive Landscape                         
    8.1    Global Brachytherapy Market BY COMPANIES                    
    8.2    Global Brachytherapy Market DEVELOPMENTS                    
                            
9    Company Profiles                         
    9.1    Boston Scientific Corporation                    
        9.1.1    OVERVIEW                
        9.1.2    PRODUCT PORTFOLIO                
        9.1.3    FINANCIALS                
        9.1.4    STRATEGIC APPROACHES THROUGH BUSINESS EXPANSION & DEVELOPMENT                
    9.2     CONMED Corporation                    
        9.2.1    OVERVIEW                
        9.2.2    PRODUCT PORTFOLIO                
        9.2.3    FINANCIALS                
        9.2.4    STRATEGIC APPROACHES THROUGH BUSINESS EXPANSION & DEVELOPMENT                
    9.3    C. R. Bard Inc.                    
        9.3.1    OVERVIEW                
        9.3.2    PRODUCT PORTFOLIO                
        9.3.3    FINANCIALS                
        9.3.4    STRATEGIC APPROACHES THROUGH BUSINESS EXPANSION & DEVELOPMENT                
    9.4    Cook Medical Incorporated                    
        9.4.1    OVERVIEW                
        9.4.2    PRODUCT PORTFOLIO                
        9.4.3    FINANCIALS                
        9.4.4    STRATEGIC APPROACHES THROUGH BUSINESS EXPANSION & DEVELOPMENT                
    9.5    Horizons International Corporation                    
        9.5.1    OVERVIEW                
        9.5.2    PRODUCT PORTFOLIO                
        9.5.3    FINANCIALS                
        9.5.4    STRATEGIC APPROACHES THROUGH BUSINESS EXPANSION & DEVELOPMENT                
    9.6    Nucletron B.V.                    
        9.6.1    OVERVIEW                
        9.6.2    PRODUCT PORTFOLIO                
        9.6.3    FINANCIALS                
        9.6.4    STRATEGIC APPROACHES THROUGH BUSINESS EXPANSION & DEVELOPMENT                
    9.7    Olympus Corporation                    
        9.7.1    OVERVIEW                
        9.7.2    PRODUCT PORTFOLIO                
        9.7.3    FINANCIALS                
        9.7.5    STRATEGIC APPROACHES THROUGH BUSINESS EXPANSION & DEVELOPMENT                
    9.8    Oncura Inc.                    
        9.8.1    OVERVIEW                
        9.8.2    PRODUCT PORTFOLIO                
        9.8.3    FINANCIALS                
        9.8.4    STRATEGIC APPROACHES THROUGH BUSINESS EXPANSION & DEVELOPMENT                
    9.9    Theragenics Corporation                    
        9.9.1    OVERVIEW                
        9.9.2    PRODUCT PORTFOLIO                
        9.9.3    FINANCIALS                
        9.9.4    STRATEGIC APPROACHES THROUGH BUSINESS EXPANSION & DEVELOPMENT                
    9.10    Varian Medical Systems Inc.                    
        9.10.1    OVERVIEW                
        9.10.2    PRODUCT PORTFOLIO                
        9.10.3    FINANCIALS                
        9.10.4    STRATEGIC APPROACHES THROUGH BUSINESS EXPANSION & DEVELOPMENT                

 

Please fill in the form below to receive a free copy of the Summary of this Report
















Global Brachytherapy Market

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
High-Dose-Rate (HDR) brachytherapy High-Dose-Rate (HDR) brachytherapy
High-Dose-Rate (HDR) brachytherapy and Pulsed-Dose-Rate brachytherapy and
Upcoming
Pulsed-Dose-Rate brachytherapy Pulsed-Dose-Rate brachytherapy
Pulsed-Dose-Rate brachytherapy and High-Dose-Rate (HDR) brachytherapy and
Upcoming
Permanent seed brachytherapy or Low-Dose-Rate (LDR) brachytherapy Permanent seed brachytherapy or Low-Dose-Rate (LDR) brachytherapy
Permanent seed brachytherapy or Low-Dose-Rate (LDR) brachytherapy and High-Dose-Rate (HDR) brachytherapy and
Upcoming
European Brachytherapy European Brachytherapy
The European Brachytherapy Market was pegged at $50 million in 2013 and expected to be $54 million by 2018. The report “European Brachytherapy Market forecast, 2010-2018 “analyzes the market of devices by segments such as High Dose Rate Brachytherapy, Pulsed Dose Rate Brachytherapy, and Permanent Seed Brachytherapy. The main companies operating in European Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
Asia-Pacific Brachytherapy Asia-Pacific Brachytherapy
The Asia-Pacific Radiation Ablation Market was pegged at $32 million in 2013 and expected to be $38 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. The main companies operating in Asia-Pacific brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
Americas Brachytherapy Americas Brachytherapy
The American Brachytherapy Market was pegged at $129 million in 2013 and expected to be $146 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. The main companies operating in Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
6 of 6 items
6 reports | Show
Connect With Us
US/CAN : +1-888-502-0539